FEMTO Pulse unveiled at AGBT 2016
Published: Tuesday, February 9th, 2016
Tags: Corporate News, FEMTO Pulse, Trade Shows
The most sensitive parallel capillary electrophoresis device ever made.
Advances in Genome Biology and Technology (AGBT) is an annual conference dedicated to furthering cutting edge genomic research. Global leaders, top researchers and industry visionaries attend to announce new discoveries, share cutting edged breakthroughs and keep abreast in the latest genome science and technology.
Advanced Analytical Technologies, Inc. (AATI) realizes the benefit of announcing new products to the diverse genomics community at AGBT. First in 2012 with their flagship product, The Fragment AnalyzerTM, and most recently at AGBT 2016, the newest in their product line, the FEMTO PulseTM.
Able to detect down to 1 fg/µl of nucleic acid and accurately size nucleic acid fragments and smears through 165,000 bp, the FEMTO Pulseis the next step in automated parallel capillary electrophoresis. Steve Siembieda, Vice President - Commercialization at AATI, presented the details of the FEMTO Pulseto a packed house on the final day of AGBT 2016. "We had a phenomenal response to the FEMTO Pulse" according to Siembieda, "The excitement about having this level of sensitivity has many in the industry thinking about where this can take their research."
Download PDF version
- AATI Strikes Multiple New Alliances in 2017
- AATI and Illumina Partner to Promote Scalable NGS QC Solutions
- AATI Expands International Presence with Opening of Offices in the United Kingdom
- Federal Scientists Issue Report, State Need for Fragment Analyzers
- FBI’s DNA Support Unit Looks to Purchase Second Fragment Analyzer